Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats

Digestion

Volumn 74, Issue 2, 2007, Pages 91-100

  Tsubouchi, Ryoichi ^a   Hayashi, Shusaku ^a   Aoi, Yoko ^a   Nishio, Hikaru ^a   Terashima, Shun ^a   Kato, Shinichi ^a   Takeuchi, Koji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Colitis healing impairment effect; COX inhibitors; Cyclooxygenase 1; Cyclooxygenase 2; Dextran sulfate sodium; Inflammatory bowel disease

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; DEXTRAN SULFATE; INDOMETACIN; MYELOPEROXIDASE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; THERAPY EFFECT; TREATMENT RESPONSE; UPREGULATION; WEIGHT REDUCTION; WOUND HEALING IMPAIRMENT;

ANIMALS; COLITIS; COLON; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DEXTRAN SULFATE; DINOPROSTONE; INTESTINAL MUCOSA; MALE; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 33846687337     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097657     Document Type: Article

References (43)

1. Whittle BJ: Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981;80:94-98.
2. Lanza FL: Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 1984;77:19-24.
3. Takeuchi K, Ueki S, Okabe S: Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986;31:114-1121.
4. O'Neil GP, Ford-Hutchinson AW: Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993;330:156-160.
5. Wang JY, Yamasaki S, Takeuchi K, Okabe S: Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology 1989;96:393-402.
6. Levi S, Goodlad RA, Lee CY, Stamp G, Walport MJ, Wright NA, Hodgson HJ: Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990;336:840-843.
7. Schmassmann A, Tarnawski AS, Peskar BM, Varga L, Flogerzi B, Halter F: Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol 1995;268(2 Pt 1):G276-G285.
8. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M: Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by specific antagonist delays healing in mice. Gastroenterology 1997;112:387-397.
9. Schmassmann A, Peskar BM, Stettler C, Netzer P, Stroff T, Flogerzi B, Halter F: Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol 1998;123:795-804.
10. Ukawa H, Yamakuni H, Kato S, Takeuchi K: Effect of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs on gastric ulcerogenic and healing responses in experimental animals. Dig Dis Sci 1998;43:2003-2011.
11. Simmonds NJ, Rampton DS: Inflammatory bowel disease - a radical view. Gut 1993;34:865-868.
12. Sharon P, Ligumsky M, Rachmilewitz D, Zor U: Role of prostaglandins in ulcerative colitis: enhanced production during active disease and inhibition by sulfasalazine Gastroenterology 1978;75:638-640.
13. 2 before and after induction of colitis with trinitrobenzene sulfonic acid in rats decreases inflammation. Gastroenterology 1989;96:1290-1300.
14. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA: Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989;97:326-337.
15. Fedrak RN, Empery LR, MacArthur C, Jewell LD: Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology 1990;98:615-625.
16. Kaufmann HJ, Taubin HL: Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 1987;107:513-516.
17. 4 synthesis. Gastroenterology 1992;102:18-27.
18. Reuter BK, Asfaha S, Buret A, Sharkey K, Wallace JL: Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 1996;98:2076-2085.
19. Okayama M, Hayashi S, Aoi Y, Nishio H, Kato S, Takeuchi K: Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats. Dig Dis Sci, in press.
20. Cooper, HS, Murthy SN, Shah RS, Sedergran DJ: Clinicopathological study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-249.
21. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-1350.
22. Ohkawa H, Ohnishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
23. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S: NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994;47:55-59.
24. Suematsu M, Suzuki M, Kitahora T, Miura S, Suzuki K, Hibi T, Watanabe M, Nagata H, Asakura H, Tsuchiya M: Increased respiratory burst of leukocytes in inflammatory bowel: the analysis of free radical generation by using chemiluminescence probe. J Clin Lab Immunol 1987;24:125-128.
25. Shiratora Y, Aoki S, Takada H, Kiriyama H, Ohto K, Hai K, Teraoka H, Matano S, Matsumoto K, Kamii K: Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 1989;44:163-171.
26. Hirata I, Murano M, Nitta M, Sasaki S, Toshina K, Maemura K, Katsu K: Estimation of mucosal inflammatory mediators in rat DSS-induced colitis. Digestion 2001;63:73-80.
27. LeDuc LE, Su KC, Guth E, Reedy T, Guth PH: Effects of cyclooxygenase and lipoxygenase inhibition on eicosanoids and healing of acetic acid colitis in rats. Dig Dis Sci 1993;38:289-294.
28. Schmassmann A, Zoidl G, Peskar BM, Waser B, Schmassmann-Suhijar D, Gebbers JO, Reubi JC: Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice. Am J Physiol Gastrointest Liver Physiol 2006;290:G747-G756.
29. Tarnawski A, Halter F: Cellular mechanisms, interactions, and dynamics of gastric ulcer healing. J Clin Gastroenterol 1995;21(Suppl 1):S93-S97.
30. Schmassmann A, Stettler C, Poulsom R, Tarasova N, Hirschi C, Flogerzi B, Matsumoto K, Nakamura T, Halter F: Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats. Gastroenterology 1997;113:1858-1872.
31. Szabo S, Khomenko T, Gombos Z, Deng XM, Jadus MR, Yoshida M: Review article: transcription factors and growth factors in ulcer healing. Aliment Pharmacol Ther 2000;14(Suppl 1):33-43.
32. Szabo S, Vincze A: Growth factors in ulcer healing: lessons from recent studies. J Physiol Paris 2000;94:77-81.
33. Satoh H, Shino A, Sato F, Asano S, Murakami I, Inatomi N, Nagaya H, Kato K, Szabo S, Folkman J: Role of endogenous basic fibroblast growth factor in the healing of gastric ulcers in rats. Jpn J Pharmacol 1997;73:59-71.
34. Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H: Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1998;94:1300-1307.
35. Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T, Hayashi K, Tsubouchi H: Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther 2003;307:146-151.
36. Matsuura M, Okazaki K, Nishio A, Nakase H, Tamaki H, Uchida K, Nishi T, Asada M, Kawasaki K, Fukui T, Yoshizawa H, Ohashi S, Inoue S, Kawanami C, Hiai H, Tabata Y, Chiba T: Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 2005;28:975-986.
37. Takahashi M, Kawabe T, Ogura K, Maeda S, Mikami Y, Kaneko N, Terano A, Omata M: Expression of vascular endothelial growth factor at the human gastric ulcer margin and in cultured gastric fibroblasts: a new angiogenic factor for gastric ulcer healing. Biochem Biophys Res Commun 1997;234:493-498.
38. Bamba H, Ota S, Kato A, Matsuzaki F: Non-steroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin- mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 1998;245:567-571.
39. Sanchez-Fidalgo S, Martin-Lacave I, Illanes M, Motilva V: Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing: effect of selective COX-2 inhibitor. Eur J Pharmacol 2004;505:187-194.
40. Miura S, Tatsuguchi A, Wada K, Takeyama H, Shinji Y, Hiratsuka T, Futagami S, Miyake K, Gudis K, Mizokami Y, Matsuoka T, Sakamoto C: Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol Gastrointest Liver Physiol 2004;287:G444-G451.
41. Pai R, Szabo IL, Kawanaka H, Soreghan BA, Jones MK, Tarnawski AS: Indomethacin inhibits endothelial cell proliferation by suppressing cell cycle proteins and PRB phosphorylation: a key to its antiangiogenic action? Mol Cell Biol Res Commun 2000;4:111-116.
42. Szabo IL, Pai R, Jones MK, Ehring GR, Kawanaka H, Tarnawski AS: Indomethacin delays gastric restitution: association with the inhibition of focal adhesion kinase and tensin phosphorylation and reduced actin stress fibers. Exp Biol Med (Maywood) 2002;227:412-424.
43. Baatar D, Jones MK, Pai R, Kawanaka H, Szabo IL, Moon WS, Kitano S, Tarnawski AS: Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor induction and extracellular signal-regulated kinase 2 activation. Am J Pathol 2002;160:963-972.